Cited by 843Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismCoronary Interventions and Diagnostics

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

Watts, G.F, Lewis, B, Lewis, E.S, Coltart, D.J, Smith, L.D.R, Swan, A.V, Brunt, J.N.H, Mann, J.I·1992·The Lancet

DOI 10.1016/0140-6736(92)90863-x

Open this paper in CoChat — free account

Abstract

To assess the effect of dietary reduction of plasma cholesterol concentrations on coronary atherosclerosis, we set up a randomised, controlled, end-point-blinded trial based on quantitative image analysis of coronary angiograms in patients with angina or past myocardial infarction. Another intervention group received diet and cholestyramine, to determine the effect of a greater reduction in circulating cholesterol concentrations. 90 men with coronary heart disease (CHD), who had a mean (SD) plasma cholesterol of 7.23 (0.77) mmol/l were randomised to receive usual care (U, controls), dietary intervention (D), or diet plus cholestyramine (DC), with angiography at baseline and at 39 (SD 3.5) months. Mean plasma cholesterol during the trial period was 6.93 (U), 6.17 (D), and 5.56 (DC) mmol/l. The proportion of patients who showed overall progression of coronary narrowing was significantly reduced by both interventions (U 46%, D 15%, DC 12%), whereas the proportion who showed an increase in luminal diameter rose significantly (U 4%, D 38%, DC 33%). The mean absolute width of the coronary segments (MAWS) studied decreased by 0.201 mm in controls, increased by 0.003 mm in group D, and increased by 0.103 mm in group DC (p less than 0.05), with improvement also seen in the minimum width of segments, percentage diameter stenosis, and edge-irregularity index in intervention groups. The change in MAWS was independently and significantly correlated with LDL cholesterol concentration and L…

Integrity signals

Registry

Crossref · 10.1016/0140-6736(92)90863-x

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B
Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159
Can lifestyle changes reverse coronary heart disease?
Ornish, D., Brown, S. E., Billings, J. H., Scherwitz, L. W., Armstrong, W. T., Ports, T. A., McLanahan, S. M., Kirkeeide, R. L., Gould, K. L., & Brand, R. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91656-u · Cited by 2,110
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010043231404 · Cited by 1,001

Show all 3 references

Research works printed but not linked: 28

Study Group, 1988, The treatment of hyperlipidaemia in adults. Recommendations of the European Atherosclerosis Society, Eur Heart J, 8, 277
Duffield, 1983, Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis, Lancet, ii, 639, 10.1016/S0140-6736(83)92527-8 · DOI
Amtzenius, 1985, Diet, lipoproteins, and the progression of coronary atherosclerosis, N Engl J Med, 312, 805, 10.1056/NEJM198503283121301 · DOI
Blankenhom, 1990, The influence of diet on the appearance of new lesions in human coronary arteries, JAMA, 263, 1646, 10.1001/jama.263.12.1646 · DOI
Lewis, 1974, Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population, Br Med J, iii, 489, 10.1136/bmj.3.5929.489 · DOI
Campeau, 1976, Grading of angina pectoris, Circulation, 54, 522, 10.1161/circ.54.3.947585 · DOI
Austen, 1975, AHA committee report. A reporting system on patients evaluated for coronary artery disease, Circulation, 51, 7, 10.1161/01.CIR.51.4.5 · DOI
Colchester, 1983, Measurement of vessel calibre and volume blood flow by dynamic quantitative digital angiography: an initial application showing variation of cerebral artery diameter with PaCO2, J Cerebr Blood Flow Metab, 3, S640
Jnh Brunt, Design, implementation, validation and use of a system for quantitative coronary cineangiography ((Rotterdam, 1989) 32 (abstr)), Third international symposium on coronary arteriography.
Brown, 1982, Arteriographic assessment of coronary atherosclerosis, Arteriosclerosis, 2, 2, 10.1161/01.ATV.2.1.2 · DOI
Crawford, 1977, Computer densitometry for angiographic assessment of arterial cholesterol content and gross pathology in human atherosclerosis, J Lab Clin Med, 89, 378
Blankenhorn, 1991, Effects of colestipolniacin therapy on human femoral atherosclerosis, Circulation, 83, 438, 10.1161/01.CIR.83.2.438 · DOI
Blankenhorn, 1987, Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts, JAMA, 257, 3233, 10.1001/jama.257.23.3233 · DOI
Kane, 1990, Regression of coronary atherosclerosis during treatment of familial hypercholesterolaemia with combined drug regimens, JAMA, 264, 1007, 10.1001/jama.264.23.3007 · DOI
Wissler, 1976, Studies of regression of advanced atherosclerosis in experimental animals and men, Ann NY Acad Sci, 275, 363, 10.1111/j.1749-6632.1976.tb43368.x · DOI
La Ville, 1989, Primary prevention of atherosclerosis by lovastatin in a genetically hyperlipidaemic rabbit strain, Atherosclerosis, 78, 205, 10.1016/0021-9150(89)90224-4 · DOI
Habib, 1984, Atherosclerosis impairs endothelium-dependent arterial relaxation, Circulation, 70, 123
Vita, 1990, Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease, Circulation, 81, 491, 10.1161/01.CIR.81.2.491 · DOI
Harrison, 1987, Restoration of endothelium-dependent arterial relaxation by dietary treatment of atherosclerosis, Circulation, 80, 1808
Vartiainen, 1947, Arteriosclerosis and wartime, Ann Med Intern Fen, 34, 705
Wilens, 1947, The resorption of arterial atheromatous deposits in wasting disease, Am J Pathol, 33, 793
Lewis, 1981, Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake, Lancet, ii, 1310, 10.1016/S0140-6736(81)91339-8 · DOI
Choudhury, 1984, A multifactorial diet in the management of hyperlipidaemia, Atherosclerosis, 50, 93, 10.1016/0021-9150(84)90011-X · DOI
Lipid Research Clinics Program, 1984, The Lipid Research Clinics coronary primary prevention trial results, I. Reduction in incidence of coronary heart disease, JAMA, 251, 351, 10.1001/jama.251.3.351 · DOI · Paper page
Brensike, 1984, Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI type II coronary intervention study, Circulation, 69, 313, 10.1161/01.CIR.69.2.313 · DOI
Ambrose, 1988, Angiographic progression of coronary artery disease and the development of myocardial infarction, J Am Coll Cardiol, 12, 56, 10.1016/0735-1097(88)90356-7 · DOI
Hackett, 1989, Coronary stenoses before and after acute myocardial infarction, Am J Cardiol, 63, 1517, 10.1016/0002-9149(89)90018-0 · DOI
Roussouw, 1990, The value of lowering cholesterol after myocardial infarction, N Engl J Med, 323, 1112, 10.1056/NEJM199010183231606 · DOI

Sorted by citations

Items 201–300 of 765

Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art
Crouse, J. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600012-jlr200 · Cited by 66
Atherosclerosis: from biology to pharmacological treatment
Riccioni, G., & Sblendorio, V. T. (2012) · 老年心脏病学杂志：英文版 · doi:10.3724/sp.j.1263.2012.02132 · Cited by 71
Lipid-Lowering Drugs in the Management of Hyperlipidaemia
Bhatnagar, D. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00018-7 · Cited by 74
Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterol.
Stewart, B. F., Brown, B., Zhao, X., Hillger, L., Sniderman, A., Dowdy, A., Fisher, L. D., & Albers, J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90635-1 · Cited by 65
Variability in the measurement of intracoronary ultrasound images: implicatioNs for the identification of atherosclerotic plaque regression
Foster, G. P., Mittleman, M. A., Koch, M., Abela, G. S., & ZARICH, S. W. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200105 · Cited by 21
Retardation and arrest of progression or regression of coronary artery disease: A review
Vos, J., de Feyter, P. J., Simoons, M. L., Tijssen, J. G. P., & Deckers, J. W. (1993) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(93)90028-c · Cited by 57
Bile Acid and Cholesterol Metabolism in Atherosclerotic Cardiovascular Disease and Therapy
Chiang, J. Y. L., Ferrell, J. M., Wu, Y., & Boehme, S. (2020) · Cardiology Plus · doi:10.4103/2470-7511.305419 · Cited by 68
“[90–93] Cholestyramine significantly reduced atherosclerosis progression in a clinical trial of patients with coronary heart disease.[94] Bile acids may be used to treat atherosclerosis by regulating lipoprotein metabolism.”
Background
Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance.
Sikand, G., Kashyap, M. L., Wong, N. D., & Hsu, J. C. (2000) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(00)00066-3 · Cited by 61
Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory.
Warnick, G., Myers, G. L., Cooper, G., & Rifai, N. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.1.11 · Cited by 61
“ATP III recommendations are solidly based on accumulating evidence concerning the contribution of lipoproteins and other risk factors in development of coronary heart disease (CHD) (3 ) and are more consistent with emerging international consensus (4, 5), for example, in increased emphasis on the risk associated with…”
Background
Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with ‘Normal’ LDL-C Levels
Superko, H., & Garrett, B. (2022) · Biomedicines · doi:10.3390/biomedicines10040829 · Cited by 60
“In STARS, the smallest LDL fraction was the plasma lipoprotein subfraction, with the single most powerful effect on coronary artery disease regression in middle-aged men with hypercholesterolemia [56].”
BackgroundMethodInfluential
Biomarkers in disease and health
Branca, F., Hanley, A. B., Pool-Zobel, B. L., & Verhagen, H. (2001) · British Journal Of Nutrition · doi:10.1079/bjn2001339 · Cited by 62
Lifestyle Modification Program in Management of Patients With Coronary Artery Disease: The Clinical Experience in a Tertiary Care Hospital
Rutledge, J. C., Hyson, D. A., Garduno, D., Cort, D. A., Paumer, L., & Kappagoda, C. T. (1999) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-199907000-00003 · Cited by 59
Individual Responses to a Cholesterol-Lowering Diet in 50 Men With Moderate Hypercholesterolemia
Denke, M., & Grundy, S. (1994) · doi:10.1001/archinte.154.3.317 · Cited by 60
Compliance enhancement. A call for multidisciplinary team approaches.
Hill, M., & Miller, N. (1996) · Circulation · doi:10.1161/01.cir.93.1.4 · Cited by 60
Intensive Nutrition Counseling Enhances Outcomes of National Cholesterol Education Program Dietary Therapy
Rhodes, K. S., Bookstein, L. C., Aaronson, L. S., Mercer, N., & Orringer, C. E. (1996) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(96)00268-4 · Cited by 51
Cholesterol reduction and its impact on coronary artery disease and total mortality
Holme, I. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80465-2 · Cited by 57
Central retinal artery occlusion
Hayreh, S. (2018) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1446_18 · Cited by 56
The Metabolic Syndrome and Cardiovascular Disease: Part 2
Jiamsripong, P., Mookadam, M., Alharthi, M. S., Khandheria, B. K., & Mookadam, F. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.00002.x · Cited by 47
Dietary fat in the prevention of cardiovascular disease — a review
Zyriax, B., & Windler, E. E. T. (2000) · European Journal of Lipid Science and Technology · doi:10.1002/(sici)1438-9312(200005)102:5 · Cited by 44
It is more important to increase the intake of unsaturated fats than to decrease the intake of saturated fats: evidence from clinical trials relating to ischemic heart disease
Mf, O. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.4.980s · Cited by 49
The biology of the artery wall in atherogenesis
O’Brien, K. D., & Chait, A. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30176-6 · Cited by 48
Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty
Wallner, Watzinger, Lindschinger, Smolle, M., Toplak, Eber, Dittrich, Elmadfa, Klein, Krejs, et al. (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00456.x · Cited by 54
Tracking atherosclerosis regression: a clinical tool in preventive cardiology
Taylor, A. J., Shaw, L. J., Fayad, Z. A., O’Leary, D., Brown, B. G., Nissen, S. E., Rader, D. J., & Raggi, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.024 · Cited by 49
Meta-analysis, Clinical Trials, and Transferability of Research Results Into Practice
Marchioli, R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.11.1158 · Cited by 59
Evidence from randomised controlled trials does not support current dietary fat guidelines: a systematic review and meta-analysis
Harcombe, Z., Baker, J. S., DiNicolantonio, J. J., Grace, F., & Davies, B. (2016) · Open Heart · doi:10.1136/openhrt-2016-000409 · Cited by 70
Will recommended changes in fat and fibre intake affect cholesterol absorption and sterol excretion? An ileostomy study
Ellegård, L., Bosaeus, I., & Andersson, H. (2000) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600940 · Cited by 53
“Dietary interventions have effects on both cholesterol levels and health (Hjermann et al, 1981; Ornish et al, 1990; Watts et al, 1992; Traeden et al, 1998).”
Background
Biological Activity of Opuntia ficus indica Cladodes II: Effect on Experimental Hypercholesterolemia in Rats
Galati, E., Tripodo, M. M., Trovato, A., d’Aquino, A., & Monforte, M. T. (2003) · doi:10.1076/phbi.41.3.175.15087 · Cited by 52
“These substances may offer some degree of protection against the onset of hypercholesterolemia and against the damage this condition can inflict (Goldstein & Brown, 1989; Manninen et al., 1992; Watts et al., 1992).”
Background
Large Artery Stiffness: Structural And Genetic Aspects
Kingwell, B. A., Medley, T. L., Waddell, T. K., Cole, T. J., Dart, A. M., & Jennings, G. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03580.x · Cited by 45
Lipoprotein subclasses and atherosclerosis.
Superko, R. (2001) · Frontiers in Bioscience · doi:10.2741/superko · Cited by 52
Lipid management: Current diet and drug treatment options
Stone, N. J. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00319-1 · Cited by 44
Exercise reduces preexisting atherosclerotic lesions in LDL receptor knock out mice
Ramachandran, S., Penumetcha, M., Merchant, N., Santanam, N., Rong, R., & Parthasarathy, S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.010 · Cited by 53
Multifactorial Evaluation of a Program for Lifestyle Behavior Change in Rehabilitation and Secondary Prevention of Coronary Artery Disease
Lisspers, C. H.-B. J. (1999) · Scandinavian Cardiovascular Journal · doi:10.1080/14017439950141975 · Cited by 50
Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases
Yntema, T., Koonen, D. P. Y., & Kuipers, F. (2023) · Nutrients · doi:10.3390/nu15081850 · Cited by 58
Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients.
Katakami, N., Kaneto, H., Osonoi, T., Saitou, M., Takahara, M., Sakamoto, F., Yamamoto, K., Yasuda, T., Matsuoka, T., Matsuhisa, M., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.035 · Cited by 51
Nail changes secondary to docetaxel
Wasner, G., Hilpert, F., Baron, R., & Pfisterer, J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04210-0 · Cited by 51
Cholesterol-Lowering Effect of Allicin on Hypercholesterolemic ICR Mice
Lu, Y., He, Z.-J., Shen, X.-Y., Xu, X.-L., Fan, J., Wu, S.-H., & Zhang, D.-Y. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/489690 · Cited by 50
“Authors of many studies have shown the relationship between high-cholesterol levels, especially HDL-C and LDLC, and the development of AS [18].”
Acute changes in serum lipids and lipoprotein subclasses in triathletes as assessed by proton nuclear magnetic resonance spectroscopy.
Yu, H. H., Ginsburg, G. S., O'Toole, M. L., Otvos, J., Douglas, P., & Rifai, N. (1999) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1945 · Cited by 50
Serial volumetric intravascular ultrasound assessment of arterial remodeling in left main coronary artery disease.
Shiran, A., Mintz, G., Leiboff, B., Kent, K., Pichard, A., Satler, L., Kimura, T., Nobuyoshi, M., & Leon, M. (1999) · American Journal of Cardiology · doi:10.1016/s0002-9149(99)00119-8 · Cited by 50
State-of-the-art update and review: clinical trials of lipid-lowering agents
Kwiterovich, P. O. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00957-6 · Cited by 54
The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.
Heinonen, T., Stein, E., Weiss, S., Mckenney, J., Davidson, M., Shurzinske, L., & Black, D. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80045-2 · Cited by 50
Advances in positron emission tomography
Carli, M. F. D. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2004.09.007 · Cited by 49
Cost-effectiveness of statins
Reckless, J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200008000-00002 · Cited by 49
A four week residential program for primary health care patients to control obesity and related heart risk factors: effective application of principles of learning and lifestyle change
Sjöström, M., Karlsson, A., Kaati, G., Yngve, A., Green, L., & Bygren, L. (1999) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600807 · Cited by 49
Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients
Kohno, M., Murakawa, K., Yasunari, K., Yokokawa, K., Horio, T., Kano, H., Minami, M., & Yoshikawa, J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90255-9 · Cited by 49
Delayed Progression or Regression of Coronary Atherosclerosis with Intensive Risk Factor Modification
Franklin, B. A., & Kahn, J. K. (1996) · Sports Medicine · doi:10.2165/00007256-199622050-00004 · Cited by 48
Indications for low-density lipoprotein apheresis.
Gordon, B. R., Stein, E. A., Jones, P. H., & Illingworth, D. (1994) · American Journal of Cardiology · doi:10.1016/0002-9149(94)90461-8 · Cited by 49
Reversal of coronary atherosclerosis. Clinical promise as the basis for noninvasive management of coronary artery disease.
Gould, K. L. (1994) · Circulation · doi:10.1161/01.cir.90.3.1558 · Cited by 44
Design and recruitment in the United States of a multicenter quantitative angiographic trial of pravastatin to limit atherosclerosis in the coronary arteries (PLAC I).
Pitt, B., Ellis, S. G., Mancini, G., Rosman, H. S., & McGovern, M. (1993) · American Journal of Cardiology · doi:10.1016/0002-9149(93)90214-w · Cited by 49
Cholesterol Lowering Modulates T Cell Function In Vivo and In Vitro
Chyu, K., Lio, W. M., Dimayuga, P. C., Zhou, J., Zhao, X., Yano, J., Trinidad, P., Honjo, T., Cercek, B., & Shah, P. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092095 · Cited by 54
“Dietary and life style intervention has been known to slow the progression or promote modest regression of atherosclerotic lesions in human as demonstrated in several randomized clinical trials [27–29], hence such intervention becomes the first step in the management of patients with atherosclerotic cardiovascular dis…”
Background
Diet and coronary heart disease: Clinical trials
Brousseau, M. E., & Schaefer, E. J. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0048-6 · Cited by 42
Diets and Clinical Coronary Events
Yancy, W. S., Westman, E. C., French, P. A., & Califf, R. M. (2003) · Circulation · doi:10.1161/01.cir.0000049205.35749.00 · Cited by 43
Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
Richter, W., Donner, M., Höfling, B., & Schwandt, P. (1998) · Metabolism: Clinical and Experimental · doi:10.1016/s0026-0495(98)90127-5 · Cited by 47
Diet and cardiovascular disease prevention: What works?
Horn, L. V., & Kavey, R.-E. W. (1997) · Annals of Behavioral Medicine · doi:10.1007/bf02892285 · Cited by 43
Assessment of coronary flow reserve and microcirculation: a clinical perspective
Campisi, R., & Carli, M. F. D. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2003.11.003 · Cited by 49
Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol
Thompson, R. L., Summerbell, C., Hooper, L., Higgins, J. P. T., Little, P. S., Talbot, D., & Ebrahim, S. B. J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001366 · Cited by 99
Lipoproteins and Cardiovascular Risk-from Genetics to CHD Prevention
Cullen, P., Funke, H., Schulte, H., & Assmann, G. (1997) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.4.51 · Cited by 31
Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular disease.
Blann, A., Maxwell, S., Burrows, G., & Miller, J. P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05541-4 · Cited by 46
Relation of saphenous vein graft obstruction to serum cholesterol levels.
Daida, H., Yokoi, H., Miyano, H., Mokuno, H., Satoh, H., Kottke, T., Hosoda, Y., & Yamaguchi, H. (1995) · Journal of the American College of Cardiology · doi:10.1097/00008483-199507000-00008 · Cited by 46
“Recently it was suggested that cholesterol-lowering therapy could retard progression and induce regression of atherosclerosis in both native coronary arteries and saphenous vein grafts (14-19).”
Background
Limitations of Angiography for Analyzing Coronary Atherosclerosis Progression or Regression
Hong, M., Mintz, G., Popma, J., Kent, K., Pichard, A., Satler, L., & Leon, M. B. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-5-199409010-00007 · Cited by 46
“Using various definitions of progression and regression, four of these studies (9-12) have shown that atherosclerosis can be stabilized, five (8, 13-16) have shown that atherosclerosis is reversible, and one (13) has shown that new lesion formation can be reduced.”
BackgroundMethod
The Association between Cholesterol and Death from Injury
Cummings, P., & Psaty, B. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00006 · Cited by 46
“lower cholesterol (62-89), plus two additional trials that attempted to lower cholesterol in patients with diabetic retinopathy (90) and cerebrovascular disease (91).”
Background
Coronary risk profiles in men with coronary artery disease: effects of body composition, fat distribution, age and fitness
Brochu, M., Poehlman, E., Savage, P., Ross, S., & Ades, P. (2000) · Coronary Artery Disease · doi:10.1097/00019501-200003000-00008 · Cited by 45
Medical nutrition therapy lowers serum cholesterol and saves medication costs in men with hypercholesterolemia.
Sikand, G., Kashyap, M. L., & Yang, I. (1998) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(98)00204-1 · Cited by 45
A brief review paper of the efficacy and safety of atorvastatin in early clinical trials.
Bakker-Arkema, R., Best, J. D., Fayyad, R., Heinonen, T., Marais, A., Nawrocki, J., & Black, D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06066-8 · Cited by 45
Metformin improves blood lipid pattern in nondiabetic patients with coronary heart disease
Carlsen, S. M., Rossvoll, O., Bjerve, K., & Følling, I. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.444790000.x · Cited by 45
Benefits and Costs of Medical Nutrition Therapy by Registered Dietitians for Patients With Hypercholesterolemia
McGEHEE, M., Johnson, E. Q., Rasmussen, H., Sahyoun, N., Lynch, M., & Carey, M. (1995) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(95)00288-x · Cited by 45
Evaluation of Colestipol/Niacin Therapy With Computer‐Derived Coronary End Point Measures: A Comparison of Different Measures of Treatment Effect
Blankenhorn, D., Selzer, R., Mack, W., Crawford, D., Pogoda, J., Lee, P., Shircore, A., & Azen, S. (1992) · Circulation · doi:10.1161/01.cir.86.6.1701 · Cited by 45
Dietary fiber and cardiovascular disease.
Marlett, J., Cho, S., & Dreher, M. (2001) · doi:10.1201/9780203904220.ch2 · Cited by 45
Arteriographic view of treatment to achieve regression of coronary atherosclerosis and to prevent plaque disruption and clinical cardiovascular events
Brown, B. G., Zhao, X.-Q., Sacco, D., & Albers, J. J. (1993) · Heart · doi:10.1136/hrt.69.1_suppl.s48 · Cited by 44
Changes of serum parameters of TiO2 nanoparticle-induced atherosclerosis in mice
Yu, X., Zhao, X., Ze, Y., Wang, L., Liu, D. H., Hong, J., Xu, B., Lin, A., Zhang, C., Zhao, Y., et al. (2014) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.08.015 · Cited by 46
Improvement of endothelium‐dependent coronary vasodilation after a single LDL apheresis in patients with hypercholesterolemia
Igarashi, K., Tsuji, M., Nishimura, M., & Horimoto, M. (2004) · Journal of clinical apheresis · doi:10.1002/jca.20000 · Cited by 44
Pathological Changes in Acute Coronary Syndromes: The Role of Statin Therapy in the Modulation of Inflammation, Endothelial Function and Coagulation
Ray, K., & Cannon, C. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-004-0205-9 · Cited by 43
LDL subfractions and atherogenicity: An hypothesis from the University of Glasgow
Packard, C. J. (1996) · Current Medical Research and Opinion · doi:10.1185/03007999609111557 · Cited by 42
Reduction in saturated fat intake for cardiovascular disease
Hooper, L., Martin, N., Jimoh, F. O., Kirk, C., Foster, E., & Abdelhamid, A. S. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011737.pub3 · Cited by 356
Recent discoveries in inclusive food-based approaches and dietary patterns for reduction in risk for cardiovascular disease
Kris-Etherton, P., Etherton, T., Carlson, J., & Gardner, C. (2002) · Current Opinion in Lipidology · doi:10.1097/00132980-200201060-00010 · Cited by 42
Lipid lowering improves endothelial functions.
Libby, P., Aikawa, M., Kinlay, S., Selwyn, A., & Ganz, P. (2000) · International Journal of Cardiology · doi:10.1016/s0167-5273(99)00105-9 · Cited by 42
Choosing the Most Appropriate Treatment for Stable Angina
Asirvatham, S., Sebastian, C., & Thadani, U. (1998) · Drug Safety · doi:10.2165/00002018-199819010-00003 · Cited by 42
Gene activation, apolipoprotein A-I/high density lipoprotein, atherosclerosis prevention and longevity.
Luoma, P. (1997) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1997.tb00032.x · Cited by 42
Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis.
Ganz, P., Creager, M., Fang, J. C., McConnell, M., Lee, R., Libby, P., & Selwyn, A. (1996) · American Journal of Medicine · doi:10.1016/s0002-9343(96)00316-6 · Cited by 42
Effects of Ramie Leaves on Improvement of Lipid Metabolism and Antiobesity Effect in Rats Fed a High Fat/High Cholesterol Diet
Lee, J.-J., Park, M.-R., Kim, A., & Lee, M. (2011) · doi:10.9721/kjfst.2011.43.1.083 · Cited by 41
Reversal of coronary atherosclerosis: Role of life style and medical management
Parsons, C. E., Agasthi, P., Mookadam, F., & Arsanjani, R. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.05.002 · Cited by 43
Rationale and design of the Rockford CHIP, a community-based coronary risk reduction program: results of a pilot phase
Englert, H. S., Diehl, H. A., & Greenlaw, R. L. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.11.007 · Cited by 38
“The participants learned how similar diets have been used successfully with CAD patients in lessening the frequency and intensity of angina [7,15,16, 20–24], in regressing atherosclerotic plaques [9,15–22], and in reducing cardiovascular events and revascularization procedures [9,16,17,19,39].”
Method
Regression of atherosclerosis: A review
SCHELL, W., & MYERS, J. N. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80041-2 · Cited by 35
Gene therapy for the vulnerable plaque
Feldman, L. J., & Isner, J. M. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00235-v · Cited by 37
“Even modest changes in coronary lumen diameter, observed in patients as a result of lipid-lowering interventions, have been associated with a substantial reduction in the incidence of acute coronary syndromes (11-18).”
Background
Aortic heterogeneity across segments and under high fat/salt/glucose conditions at the single-cell level
He, D., Mao, A., Zheng, C., Kan, H., Zhang, K., Zhang, Z., Feng, L., & Ma, X. (2020) · National Science Review · doi:10.1093/nsr/nwaa038 · Cited by 44
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT).
Kleemann, A., Eckert, S., von Eckardstein, A., Lepper, W., Schernikau, U., Gleichmann, U., Hanrath, P., Fleck, E., Neiss, A., Kerber, S., et al. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1483 · Cited by 38
Effect of pravastatin (10 mg/day) on progression of coronary atherosclerosis in patients with serum total cholesterol levels from 160 to 220 mg/dl and angiographically documented coronary artery disease. Coronary Artery Regression Study (CARS) Group.
Tamura, A., Mikuriya, Y., & Nasu, M. (1997) · American Journal of Cardiology · doi:10.1016/s0002-9149(97)00010-6 · Cited by 38
Serum sialic acid as an indicator of change in coronary artery disease.
Watts, G. F., Crook, M., Haq, S., & Mandalia, S. (1995) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(95)90256-2 · Cited by 38
Self-citation
Efficacy and Safety of Once-Daily vs Twice-Daily Dosing With Fluvastatin, a Synthetic Reductase Inhibitor, in Primary Hypercholesterolemia
Insull, W. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420210087010 · Cited by 39
Plaque stabilization: A mechanism for the beneficial effect of lipid-lowering therapies in angiography studies
Waters, D. D. (1994) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(05)80038-6 · Cited by 35
Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B.
Zhao, X.-Q., Brown, B. G., Hillger, L. A., Sacco, D., Bisson, B., Fisher, L. D., & Albers, J. J. (1993) · Circulation · doi:10.1161/01.cir.88.6.2744 · Cited by 35
Atherosclerosis regression, plaque disruption, and cardiovascular events: a rationale for lipid lowering in coronary artery disease.
Brown, B. G., Zhao, X., Sacco, D., & Albers, J. J. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.002053 · Cited by 38
Predictive Value of Lipid Profile for Salutary Coronary Angiographic Changes in Patients on a Low-Fat Diet and Physical Exercise Program
Niebauer, J., Hambrecht, R., Velich, T., Marburger, C., Hauer, K. A., Kreuzer, J., Zimmermann, R., von Hodenberg, E., Schlierf, G., Schuler, G. C., et al. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)90390-2 · Cited by 27
The influence of pretreatment lew density lipoprotein cholesterol concentrations on the effect of hypocholesterolemic therapy on coronary atherosclerosis in angiographic trials
Sacks, F. M., Gibson, C. M., ROSNER, B. A., Pasternak, R. C., & Stone, P. H. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80475-5 · Cited by 40
Alcohol consumption and coronary atherosclerosis progression—the Stockholm Female Coronary Risk Angiographic Study
Janszky, I., Mukamal, K. J., Orth-Gomér, K., Romelsjö, A., Schenck-Gustafsson, K., Svane, B., Kirkeeide, R. L., & Mittleman, M. A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.012 · Cited by 36
Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Martin, N., Bridges, C., Brainard, J. S., Wang, X., Brown, T. J., Hanson, S., Jimoh, F. O., Ajabnoor, S. M., Deane, K. H., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012345.pub2 · Cited by 194
Influence of material property variability on the mechanical behaviour of carotid atherosclerotic plaques: A 3D fluid-structure interaction analysis
Yuan, J., Teng, Z., Feng, J.-X., Zhang, Y.-X., Brown, A. J., Gillard, J., Jing, Z., & Lu, Q. (2015) · International Journal for Numerical Methods in Biomedical Engineering · doi:10.1002/cnm.2722 · Cited by 36
“Moreover, clinical trials have shown that lipid-lowering therapy may reduce the incidence of cardiovascular events [41, 42] by transforming cholesterol esters to cholesterol monohydrate.”
Background
Meta-Analysis of the Effects of Lifestyle Modifications on Coronary and Carotid Atherosclerotic Burden
Jhamnani, S., Patel, D. B., Heimlich, L., King, F., Walitt, B. T., & Lindsay, J. M. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.10.035 · Cited by 37
Bile acid sequestrants
Out, C., Groen, A. K., & Brufau, G. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32834f0ef3 · Cited by 85
Acute Effect of Atorvastatin on Coronary Circulation Measured by Transthoracic Doppler Echocardiography in Patients Without Coronary Artery Disease by Angiography
Hinoi, T., Matsuo, S., Tadehara, F., Tsujiyama, S., & Yamakido, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.02.050 · Cited by 32
Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease
Aquilani, R. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1402 · Cited by 35

Authors: Watts, G. F., Lewis, B., Lewis, E. S., Coltart, D. J., Smith, L. D. R., Swan, A. V., Brunt, J. N. H., & Mann, J. I.
Affiliations: St Thomas' Hospital (GB)
University of Manchester (GB)
University of Otago (NZ)
ORCID: Watts, G.F
Lewis, B
Venue: The Lancet
Publisher: Elsevier BV
Published: 1992-03
Volume: 339
Issue: 8793
Pages: 563-569
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/0140-6736(92)90863-x
OpenAlex: W2132942256
Cited by: 843
References: 34
Citations by year: 2026: 2 · 2025: 4 · 2024: 9 · 2023: 8 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 9 · 2015: 10 · 2014: 10 · 2013: 15 · 2012: 11
FWCI: 103.88
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Keywords: coronary artery disease, lipid-lowering diet, cholestyramine, dietary cholesterol reduction, coronary atherosclerosis regression, coronary angiography, coronary lumen diameter, LDL cholesterol, LDL/HDL ratio, cardiovascular events, hypercholesterolemia
MeSH terms: Angina Pectoris, Cholesterol, Cholestyramine Resin, Combined Modality Therapy, Coronary Artery Disease, Coronary Disease, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Remission Induction, Treatment Outcome, Coronary Angiography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks